Filament Health Statistics
Total Valuation
Filament Health has a market cap or net worth of 4.37 million. The enterprise value is 4.44 million.
| Market Cap | 4.37M |
| Enterprise Value | 4.44M |
Important Dates
The next estimated earnings date is Thursday, August 14, 2025.
| Earnings Date | Aug 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Filament Health has 261.79 million shares outstanding. The number of shares has increased by 27.08% in one year.
| Current Share Class | 261.79M |
| Shares Outstanding | 261.79M |
| Shares Change (YoY) | +27.08% |
| Shares Change (QoQ) | +0.03% |
| Owned by Insiders (%) | 37.78% |
| Owned by Institutions (%) | 19.57% |
| Float | 92.53M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 14.88 |
| PB Ratio | 6.45 |
| P/TBV Ratio | 12.22 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.30 |
| EV / Sales | 15.11 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -4.01 |
Financial Position
The company has a current ratio of 0.16, with a Debt / Equity ratio of 0.23.
| Current Ratio | 0.16 |
| Quick Ratio | 0.15 |
| Debt / Equity | 0.23 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.14 |
| Interest Coverage | -27.31 |
Financial Efficiency
Return on equity (ROE) is -347.26% and return on invested capital (ROIC) is -104.08%.
| Return on Equity (ROE) | -347.26% |
| Return on Assets (ROA) | -64.32% |
| Return on Invested Capital (ROIC) | -104.08% |
| Return on Capital Employed (ROCE) | -363.23% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 13 |
| Asset Turnover | 0.11 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -58.15% in the last 52 weeks. The beta is 1.02, so Filament Health's price volatility has been similar to the market average.
| Beta (5Y) | 1.02 |
| 52-Week Price Change | -58.15% |
| 50-Day Moving Average | 0.02 |
| 200-Day Moving Average | 0.03 |
| Relative Strength Index (RSI) | 46.70 |
| Average Volume (20 Days) | 29,722 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Filament Health had revenue of 293,753 and -3.42 million in losses. Loss per share was -0.01.
| Revenue | 293,753 |
| Gross Profit | 293,753 |
| Operating Income | -2.65M |
| Pretax Income | -3.42M |
| Net Income | -3.42M |
| EBITDA | -2.59M |
| EBIT | -2.65M |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 90,751 in cash and 156,858 in debt, giving a net cash position of -66,107 or -0.00 per share.
| Cash & Cash Equivalents | 90,751 |
| Total Debt | 156,858 |
| Net Cash | -66,107 |
| Net Cash Per Share | -0.00 |
| Equity (Book Value) | 677,898 |
| Book Value Per Share | 0.00 |
| Working Capital | -1.09M |
Cash Flow
In the last 12 months, operating cash flow was -1.09 million and capital expenditures -20,353, giving a free cash flow of -1.11 million.
| Operating Cash Flow | -1.09M |
| Capital Expenditures | -20,353 |
| Free Cash Flow | -1.11M |
| FCF Per Share | -0.00 |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -901.33% |
| Pretax Margin | -1,162.92% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Filament Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -27.08% |
| Shareholder Yield | -27.08% |
| Earnings Yield | -78.14% |
| FCF Yield | -25.31% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |